title: Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: effect of pH and serum.
abstract: This study was designed to systematically evaluate the influence of pH and serum on the transfection process of chitosan-DNA complexes, with the objective of maximizing their efficiency. The hydrodynamic diameter of the complexes, measured by dynamic light scattering (DLS), was found to increase with salt and pH from 243 nm in water to 1244 nm in PBS at pH 7.4 and aggregation in presence of 10% serum. The cellular uptake of complexes into HEK 293 cells assessed by flow cytometry and confocal fluorescent imaging was found to increase at lower pH and serum. Based on these data, new methodology were tested and high levels of transfection (>40%) were achieved when transfection was initiated at pH 6.5 with 10% serum for 8-24 h to maximize uptake and then the media was changed to pH 7.4 with 10% serum for an additional 24-40 h period. Cytotoxicity of chitosan/DNA complexes was also considerably lower than Lipofectamine. Our study demonstrates that the evaluation of the influence of important parameters in the methodology of transfection enables the understanding of crucial physicochemical and biological mechanisms which allows for the design of methodologies maximising transgene expression.
authors.affiliation: Department of Chemical Engineering, Institute of Biomedical Engineering, Ecole Polytechnique of Montreal, P.O. Box 6079, Station Centre-Ville, Montreal, QC, H3C 3A7, Canada.
authors.forename: Surendra
authors.initials: S
authors.lastname: Nimesh
authors.forename: Marc M
authors.initials: MM
authors.lastname: Thibault
authors.forename: Marc
authors.initials: M
authors.lastname: Lavertu
authors.forename: Michael D
authors.initials: MD
authors.lastname: Buschmann
mesh_terms: D000818:Animals; D002417:Cattle; D048271:Chitosan; D004247:DNA / Q000008:administration & dosage* / Q000378:metabolism*; D018014:Gene Transfer Techniques; D057809:HEK293 Cells; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008156:Luciferases / Q000032:analysis; D014162:Transfection / Q000379:methods*
chemical_list: D004247:DNA; D048271:Chitosan; D008156:Luciferases
references.citation: Pharm Res. 2003 Nov;20(11):1812-9
references.pmid: 14661926
references.citation: J Control Release. 2006 May 15;112(2):223-8
references.pmid: 16556468
references.citation: Biotechnol Bioeng. 2000 Mar 5;67(5):585-97
references.pmid: 10649233
references.citation: Proc Natl Acad Sci U S A. 1974 Apr;71(4):1286-90
references.pmid: 4524638
references.citation: Biomacromolecules. 2007 Oct;8(10):3224-34
references.pmid: 17850110
references.citation: Biomacromolecules. 2009 Jun 8;10(6):1490-9
references.pmid: 19419142
references.citation: Eur J Pharm Biopharm. 2006 Jan;62(1):17-25
references.pmid: 16257520
references.citation: Biomaterials. 2006 Mar;27(9):2060-5
references.pmid: 16202449
references.citation: Eur J Pharm Biopharm. 2004 Jan;57(1):1-8
references.pmid: 14729076
references.citation: Biomaterials. 2003 Mar;24(7):1121-31
references.pmid: 12527253
references.citation: Sci Am. 1997 Jun;276(6):102-6
references.pmid: 9163942
references.citation: Biomaterials. 2009 Mar;30(9):1797-808
references.pmid: 19110309
references.citation: J Immunol Methods. 1997 May 26;204(2):205-8
references.pmid: 9212838
references.citation: Biotechnol Prog. 1991 Nov-Dec;7(6):481-94
references.pmid: 1367750
references.citation: Adv Drug Deliv Rev. 2003 Apr 25;55(4):483-99
references.pmid: 12706047
references.citation: Biomaterials. 2006 Sep;27(27):4815-24
references.pmid: 16725196
references.citation: Adv Drug Deliv Rev. 2001 Nov 5;52(2):145-50
references.pmid: 11718938
references.citation: Bioconjug Chem. 2006 Mar-Apr;17(2):309-16
references.pmid: 16536460
references.citation: Mol Cell Biol. 1987 Feb;7(2):725-37
references.pmid: 3821727
references.citation: Pharm Res. 1997 Jul;14(7):923-9
references.pmid: 9244151
references.citation: Science. 1989 Nov 3;246(4930):603-8
references.pmid: 2683075
references.citation: Int J Pharm. 2006 Jun 6;315(1-2):44-51
references.pmid: 16563672
references.citation: Gene Ther. 2009 Sep;16(9):1097-110
references.pmid: 19440230
references.citation: Int J Pharm. 1999 Feb 15;178(2):231-43
references.pmid: 10205643
references.citation: Int J Pharm. 2003 Feb 18;252(1-2):263-6
references.pmid: 12550802
references.citation: Biotechnol Bioeng. 1988 Oct 5;32(8):947-65
references.pmid: 18587813
references.citation: Gene Ther. 1996 Mar;3(3):269-73
references.pmid: 8646559
references.citation: Pharm Res. 1998 Sep;15(9):1332-9
references.pmid: 9755882
references.citation: Curr Opin Biotechnol. 2002 Apr;13(2):128-31
references.pmid: 11950563
references.citation: J Control Release. 1998 Dec 4;56(1-3):259-72
references.pmid: 9801449
references.citation: J Control Release. 2005 Sep 2;106(3):391-406
references.pmid: 15967533
references.citation: Biomaterials. 2001 Aug;22(15):2075-80
references.pmid: 11432586
references.citation: J Drug Target. 2004 Jun;12(5):281-8
references.pmid: 15512779
references.citation: J Immunol Methods. 1998 Apr 15;213(2):157-67
references.pmid: 9692848
references.citation: J Control Release. 2001 Feb 23;70(3):399-421
references.pmid: 11182210
references.citation: Int J Pharm. 2002 Oct 1;245(1-2):83-91
references.pmid: 12270245